Top Markets
#1 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +593.28%
#2 Phala Phala +59.93%
#3 Bitway Bitway +34.54%
#4 Backpack Backpack +33.40%
#5 龙虾 (Lobster) 龙虾 (Lobster) +25.98%
#6 ARK ARK +24.60%
#7 Mubarak Mubarak +23.76%
#8 The Black Bull The Black Bull +22.66%
#9 Aerodrome Finance Aerodrome Finance +20.05%
#10 PulseChain PulseChain +19.86%
Coin of the day
Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain)
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Pozycja w akcjach #492
Operating globally, Becton, Dickinson and Company (BD) is a prominent... Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.
Cena akcji
$183.43
Kapitalizacja rynkowa
$50.54B
Zmiana (1 dzień)
2.13%
Zmiana (1 rok)
29.20%
Kraj
US
Handel Becton, Dickinson and Company (BDX)

Kategoria

Healthcare
Marża operacyjna dla Becton, Dickinson and Company (BDX)
Marża operacyjna na dzień September 2026 TTM: 9.83%
Według najnowszych raportów finansowych i ceny akcji Becton, Dickinson and Company, bieżąca marża operacyjna (TTM) wynosi 9.83%. Na koniec 2024 wynosiła 11.88%.
Historia marży operacyjnej dla Becton, Dickinson and Company od 2000 do 2026
Marża operacyjna na koniec każdego roku
Rok Marża operacyjna Zmień
2026 (TTM) 9.83% -16.69%
2025 11.80% -0.67%
2024 11.88% 8.99%
2023 10.90% -9.84%
2022 12.09% 2.81%
2021 11.76% 107.41%
2020 5.67% -44.30%
2019 10.18% 7.84%
2018 9.44% -25.02%
2017 12.59% 9.86%
2016 11.46% 9.67%
2015 10.45% -45.03%
2014 19.01% 22.09%
2013 15.57% -22.96%
2012 20.21% -8.01%
2011 21.97% -1.08%
2010 22.21% -2.37%
2009 22.75% 4.74%
2008 21.72% 14.80%
2007 18.92% -4.88%
2006 19.89% 4.52%
2005 19.03% 19.31%
2004 15.95% -6.45%
2003 17.05% 0.12%
2002 17.03% -0.99%
2001 17.20% 8.72%
2000 15.82% 0.00%
Marża operacyjna dla podobnych firm lub konkurentów
Firma Marża operacyjna Różnica w marży operacyjnej Kraj
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
31.28% -96.82%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
12.36% -98.74%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
0.00% -
JP
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
0.00% -
CH
Medline Inc. Medline Inc.
Medline Inc.
MDLN.US
0.00% -
US
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.